Abstract

Introduction: Chronic mechanical low back pain (CMLBP) can be caused by impaired neuromuscular control and degeneration of the multifidus muscles resulting in functional instability of the lumbar spine. Available treatment options often lack long-term effectiveness and prognosis is unfavourable. An implantable Restorative Neurostimulation system (ReActiv8® by Mainstay Medical), that stimulates the L2 medial branches of the dorsal rami to reactivate neuromuscular control, received FDA Premarket Approval based on evidence from the ReActiv8-B pivotal trial (clinicaltrials.gov/show/NCT02577354).

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.